Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30011282
Basic Information
VIS ID
TVIS30011282
Fusion event
HIV-EVI5 integration
Validated
No
Detection method
QiaQuick PCR and Sequencing
Data source
download(RID)
Sample type
Cell line
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2013
PubMed ID
23953889
Virus Sequence
Virus name
HIV
Reference genome
Not given
Host Sequence
Chromosome
chr1
Cytoband
p22.1
Reference genome
GRCh37/hg19
Start
93053591/92588034 (Hg38)
End
93053591/92588034 (Hg38)
Orient
+
Location type
Intronic
Fragile sites / regions
FRA1D
Target gene
EVI5
miRNAs that regulate target gene
hsa-mir-124-3p
;
hsa-mir-96-5p
;
hsa-mir-182-5p
;
hsa-mir-3607-3p
;
hsa-mir-4470
;
hsa-mir-194-3p
;
hsa-mir-5094
;
hsa-mir-5693
;
hsa-mir-6511a-5p
;
hsa-mir-1910-3p
;
hsa-mir-3714
;
hsa-mir-577
;
hsa-mir-551b-5p
;
hsa-mir-548an
;
hsa-mir-1271-5p
;
hsa-mir-190a-3p
;
hsa-mir-5011-5p
;
hsa-mir-1277-5p
;
hsa-mir-5580-3p
;
hsa-mir-7-2-3p
;
hsa-mir-7-1-3p
;
hsa-mir-493-5p
;
hsa-mir-494-3p
;
hsa-mir-944
;
hsa-mir-665
;
hsa-mir-6513-5p
;
hsa-mir-887-5p
;
hsa-mir-3913-5p
;
hsa-mir-3122
;
hsa-mir-450a-1-3p
;
hsa-mir-6779-5p
;
hsa-mir-6780a-5p
;
hsa-mir-3689c
;
hsa-mir-3689b-3p
;
hsa-mir-3689a-3p
;
hsa-mir-30b-3p
;
hsa-mir-1273h-5p
;
hsa-mir-6788-5p
;
hsa-mir-30c-2-3p
;
hsa-mir-30c-1-3p
;
hsa-mir-6765-5p
;
hsa-mir-7977
;
hsa-mir-3165
;
hsa-mir-6745
;
hsa-mir-363-5p
;
hsa-mir-6799-5p
;
hsa-mir-6883-5p
;
hsa-mir-6785-5p
;
hsa-mir-4728-5p
;
hsa-mir-149-3p
;
hsa-mir-7106-5p
;
hsa-mir-7160-5p
;
hsa-mir-3656
;
hsa-mir-6884-5p
;
hsa-mir-485-5p
;
hsa-mir-6087
;
hsa-mir-3197
;
hsa-mir-4649-3p
;
hsa-mir-383-3p
;
hsa-mir-6500-3p
;
hsa-mir-3614-5p
;
hsa-mir-4478
;
hsa-mir-4419b
;
hsa-mir-3929
;
hsa-mir-32-5p
;
hsa-mir-92b-3p
;
hsa-mir-92a-3p
;
hsa-mir-135b-5p
;
hsa-mir-1247-3p
;
hsa-mir-1255b-2-3p
;
hsa-mir-126-3p
;
hsa-mir-3689d
;
hsa-mir-377-5p
;
hsa-mir-455-3p
;
hsa-mir-487b-3p
;
hsa-mir-6086
;
hsa-mir-6134
;
hsa-mir-6499-3p
;
hsa-mir-6516-5p
;
hsa-mir-6807-5p
;
hsa-mir-6851-5p
;
hsa-mir-6880-5p
;
hsa-mir-7847-3p
Nearest miRNA
hsa-mir-101-1/Upstream/6230347; hsa-mir-11399/Downstream/1258798;
Nearest TSS
ENST00000473358/Upstream/101158;
ENST00000646852/Downstream/37900;
Nearest CpG islands
None/Target,
chr1-CpG: 111/Upstream/100982
,
chr1-CpG: 105/Downstream/196347
Nearest cancer related gene
EVI5
(OG, No orient, 0)
Upstream sequence
ATACTAGAAGGCTTGGGTTTAATTCTCACCTATTTTCCTTAACTAACTGAGGAAAAAATTGACTTTTCTATGTTTTGTTCTACTCCATGGAATTTAGAGA
Downstream sequence
TAGCTCCATTTAGTATTAATGTAAAAATAAAGTCTTCAAATAATAAATAGCATTTAGATGGTGGAAAACTCCAGTAATAAGAGGAAACTTAATTTTTTAA
Reference
Sherrill-Mix, S., et al. HIV latency and integration site placement in five cell-based models.2013, Retrovirology 10: 90.
Sample Information
×
Sample name
Resting CD4+
Sample type
Cell line
Gender
Female
CpG Island Information
×
Download
Curate